Addiction News and Research

RSS

Barcelona to host European Drosophila Research Conference

From 16 to 19 October, more than 700 international scientists will attend the European Drosophila Research Conference, the most important European conference focused on basic and biomedical research that uses the fly fruit, Drosophila melanogaster, as a model system.

15 Oct 2013

High doses of ADHD drugs may be effective for people with amphetamine dependency

People with ADHD and dependency rarely respond as they should to ADHD drugs. A randomised study from Karolinska Institutet in Sweden now shows that it is possible to obtain the desired efficacy by administering the drug in higher doses.

15 Oct 2013

Genetic variation can affect how people see and experience the world

A new study by a University of British Columbia researcher finds that some people are genetically predisposed to see the world darkly.

11 Oct 2013

Alkermes' ALKS 5461 drug gets FDA Fast Track status for major depressive disorder

Alkermes plc today announced that the U.S. Food and Drug Administration has granted Fast Track status for ALKS 5461 for the adjunctive treatment of major depressive disorder in patients with an inadequate response to standard therapies.

10 Oct 2013

How Obamacare affects children, prisoners

Media reports explore how the health law requires that dental and vision care benefits for children be included in policies sold through new online insurance marketplaces and how the law may shift prisoners' health care costs from local jurisdictions to the federal government.

10 Oct 2013

Study proposes novel treatment for narcolepsy

Lancet Neurology, a prestigious journal in its domain, publishes in its last issue, an article entitled "Pitolisant versus placebo and modafinil in patients with narcolepsy: a double-blind randomised trial" authored by Y. Dauvilliers and others from the HARMONY I study group which proposes a novel treatment for this orphan disease. It is accompanied by a Commentary entitled "A need for new treatments in narcolepsy".

10 Oct 2013

Asthma infection risk ‘goes beyond the airways’

Researchers from the USA have found that asthma may be associated with an increased risk for infections outside of the respiratory tract.

9 Oct 2013

Alkermes announces plans to advance ALKS 5461 phase 3 program for major depressive disorder

Alkermes plc today announced that it has successfully completed its End-of-Phase 2 interactions with the U.S. Food and Drug Administration (FDA), and the company plans to advance ALKS 5461 into phase 3 development in early 2014.

9 Oct 2013

Binge eating disorder is different from anorexia nervosa and bulimia nervosa

Food addiction is not yet recognised as a mental disorder but certain obese individuals clearly display addictive-like behaviour towards food.

9 Oct 2013

Report: States lax in taking steps to curb prescription drug abuse

The number of deaths attributed to the abuse of painkillers and other prescription drugs has risen sharply in recent years.

9 Oct 2013

Alkermes completes patient enrollment in phase 3 study of aripiprazole lauroxil in schizophrenia patients

Alkermes plc (NASDAQ: ALKS) today announced completion of patient enrollment in the pivotal, multinational phase 3 study evaluating aripiprazole lauroxil in patients with schizophrenia.

9 Oct 2013

MNK-795 for acute pain management: an interview with Dr Lynn Webster

MNK-795 is a product in development that is intended to be used for acute pain. It has some unique properties. First, it is an extended release formulation, meaning that it’s going to last more than three to four hours. It was studied to be dosed once every 12 hours, and that is unique for an acute pain formulation.

8 Oct 2013

First Edition: October 8, 2013

Today's headlines include the latest on how the health law's online insurance marketplaces are operating and what caused the initial systemic problems.

8 Oct 2013

Babies born to moms who smoked when pregnant have increased risk of nicotine addiction in adulthood

Adult women whose mothers had increased levels of stress hormones while they were pregnant are at greater risk of becoming addicted to nicotine, according to a new study led by a Miriam Hospital researcher.

8 Oct 2013

ERK pathway discovery may provide therapeutic options for treating drug addictions

The extracellular-signal regulated kinase (ERK) pathway plays a role in multiple drug addictions and appears to modulate neuronal plasticity through epigenetic mechanisms, say French scientists.

7 Oct 2013

Self-medication is key reason for prescription drug abuse in docs

...

5 Oct 2013

Researchers receive prestigious European Health Award for project on new psychoactive drugs

The prestigious European Health Award 2013 has been awarded to Dr Ornella Corazza for the Recreational Drugs European Network (ReDNet), a collaborative prevention project on new psychoactive drugs led by University of Hertfordshire researchers Professor Fabrizio Schifano and Dr Corazza.

5 Oct 2013

Report: Doctors who abuse prescription drugs often do so for "self-medication"

Doctors who abuse prescription drugs often do so for "self-medication"—whether for physical or emotional pain or stress relief, reports a study in the October Journal of Addiction Medicine, the official journal of the American Society of Addiction Medicine.

5 Oct 2013

Study assess use of prescription painkillers for chronic pain among patients pre- and post-obesity surgery

Chronic use of prescription painkillers, also known as opioids, among obese patients prior to bariatric surgery continues after surgery, according to a new Kaiser Permanente study published today in the Journal of the American Medical Association.

2 Oct 2013

Data from Boehringer Ingelheim's HCV clinical program accepted for presentation at The Liver Meeting

New data from Boehringer Ingelheim's hepatitis C virus clinical development program have been accepted for presentation at the 64th Annual Meeting of the American Association for the Study of Liver Diseases, also known as The Liver Meeting®, taking place November 1-5 in Washington, D.C.

1 Oct 2013

Addiction News and Research

Barcelona to host European Drosophila Research Conference

High doses of ADHD drugs may be effective for people with amphetamine dependency

Genetic variation can affect how people see and experience the world

Alkermes' ALKS 5461 drug gets FDA Fast Track status for major depressive disorder

How Obamacare affects children, prisoners

Study proposes novel treatment for narcolepsy

Asthma infection risk ‘goes beyond the airways’

Alkermes announces plans to advance ALKS 5461 phase 3 program for major depressive disorder

Binge eating disorder is different from anorexia nervosa and bulimia nervosa

Report: States lax in taking steps to curb prescription drug abuse

Alkermes completes patient enrollment in phase 3 study of aripiprazole lauroxil in schizophrenia patients

MNK-795 for acute pain management: an interview with Dr Lynn Webster

First Edition: October 8, 2013

Babies born to moms who smoked when pregnant have increased risk of nicotine addiction in adulthood

ERK pathway discovery may provide therapeutic options for treating drug addictions

Self-medication is key reason for prescription drug abuse in docs

Researchers receive prestigious European Health Award for project on new psychoactive drugs

Report: Doctors who abuse prescription drugs often do so for "self-medication"

Study assess use of prescription painkillers for chronic pain among patients pre- and post-obesity surgery

Data from Boehringer Ingelheim's HCV clinical program accepted for presentation at The Liver Meeting

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News